Development of an electrochemical-surface plasmon dual biosensor based on carboxylated conducting polymer thin films

The preparation and characterization of electrosynthesized poly(o-phenylenediamine) (PPD) imprinted by glucose (iPPD) is reported as the first case of an electrosynthesized polymer molecularly imprinted by a neutral template. The material is employed as the recognition element of a QCM biomimetic sensor for glucose. Scatchard analysis of the relevant calibration curve offers information on the equilibrium and binding sites involved in glucose detection. XPS comparison of PPD and iPPD supports the occurrence of a templating effect. On this basis, molecular imprinting electropolymerization is proposed as a possible strategy for the preparation of new materials with molecular recognition properties to be applied in biomimetic sensors.

Circulating tumor DNA (ctDNA) bearing tumor-specific mutation and methylation are promising biomarkers for noninvasive cancer assessment. However, existing methods for ctDNA detection are restricted to genetic mutations. Recently, nanoplasmonics has emerged as a platform for one-step dual detection with high sensitivity and specificity. Here we present a strategy for ultrasensitive detection of tumor-specific mutations (E542K and E545K) and methylation of ctDNA of PIK3CA gene based on localized surface plasmon resonance (LSPR) and the coupling plasmon mode of gold nanoparticles (AuNPs). Peptide nucleic acids (PNA) is used as a probe to capture and enrich the 69-bp PIK3CA ctDNA. The exposure of PNA-probed AuNPs to 200 fM ctDNA generates LSPR-peak shift of 4.3 nm, corresponding to the primary response. Immunogold colloids are exploited as methylation detectors and plasmon coupling based enhancement for secondary response. LSPR-peak shifted from 4.3 nm to 11.4 nm upon the immunogold colloids binding to two methylcytosines (mCpG), which is an approximately 107% increase, compared to that of the primary response. This enhancement leads to four times (~50 fM) improvement of sensitivity and because of two mCpG sites, ctDNA was detected. These results demonstrate that the sensor can simultaneously detect the hot-spot mutation and epigenetic changes on the ctDNA. Promisingly, other specific-tumor mutants and epigenetic changes can be detected at low concentration with this platform.